Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 1999

View Archived Issues

Nexell awarded U.S. patent for neutropenia therapy

Avanir signs letter of intent with IriSys for ALS drug

NIH to initiate clinical trials of Novavax's Novasome spermicide

Ligand seeks approval for Panretin Gel in Europe

Alkermes acquires Advanced Inhalation Research

Orion seeks approval for injectable levosimendan in the U.S.

Cholesterol-lowering action of troglitazone points to a potential new target for hypolipidemic drugs

Fenamate-derived antiinflammatory agents in development at Abbott

G120K-PEG: a specific renal GHR antagonist for the treatment of diabetic kidney disease

Cathepsin L inhibitor isolated by Yamanouchi

New antibacterial series produced by Streptomyces discovered by Kyowa Hakko

Otsuka's new anti-H. pylori agents for GI disorders

Effects of NS-7 on Ca2+ channel subtypes and NOS

Cardioprotective agent JTV-519 evaluated for neuronal effects

Effects of NS-105 on cAMP production involve different mGluR groups

Dexemel drug delivery vehicle approved in the U.K.

Boston team reports further successes with naked DNA gene transfer as therapy for angina

ECyd evaluated for mechanism of action, potential clinical activity

Anti-CMV MAb slows disease progression in AIDS patients

Trovan I.V. potentially incompatible with normal saline and lactated Ringer's solutions

Lexigen's HIV fusion inhibitor is safe and effective in phase II trial

Combination of TZT-1027 + ara-C provides synergistic antitumor activity

Inadvertent overdoses of Cerebyx due to labeling confusion lead to death

Inflazyme and HMR to collaborate on allergy, asthma and respiratory disease therapies

Biota's inhaled influenza drug recommended for approval in Australia

NIAID opens phase I trial of vCP205 in Uganda

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...